{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:01:01Z","timestamp":1793070061901,"version":"4.5.0"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014677","name":"Universitatea de Medicin\u0103 Farmacie \u0218tiin\u021be \u0219i Tehnologie George Emil Palade din T\u00e2rgu Mure\u0219","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.prp.2024.155406","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T13:34:27Z","timestamp":1718285667000},"page":"155406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Pathogenetic and molecular classifications of soft tissue and bone tumors: A 2024 update"],"prefix":"10.1016","volume":"260","author":[{"given":"Andrei Ionut","family":"Patrichi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Gurzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2024.155406_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/dc.25013","article-title":"Molecular testing of soft tissue tumors","volume":"51","author":"Rottmann","year":"2023","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.prp.2024.155406_bib2","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.5858\/1999-123-1246-MPOSTA","article-title":"Molecular pathology of soft tissue and bone tumors","volume":"123","author":"Slominski","year":"1999","journal-title":"Arch. Pathol. Lab Med"},{"key":"10.1016\/j.prp.2024.155406_bib3","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.suc.2016.06.003","article-title":"Bone and soft tissue pathology","volume":"96","author":"Gibbs","year":"2016","journal-title":"Surg. Clin. North Am."},{"key":"10.1016\/j.prp.2024.155406_bib4","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.3390\/cancers15092449","article-title":"Cancer stem cells in sarcomas: in vitro isolation and role as prognostic markers: a systematic review","volume":"15","author":"Chico","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2024.155406_bib5","doi-asserted-by":"crossref","first-page":"5934","DOI":"10.3390\/ijms24065934","article-title":"The recent advances in molecular diagnosis of soft tissue tumors","volume":"24","author":"Choi","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2024.155406_bib6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00428-009-0828-5","article-title":"Molecular pathology of sarcomas: concepts and clinical implications","volume":"456","author":"Bov\u00e9e","year":"2010","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2024.155406_bib7","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.ejso.2022.02.005","article-title":"New developments in the pathology and mo-lecular biology of retroperitoneal sarcomas.","volume":"49","author":"Watson","year":"2023","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.prp.2024.155406_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1384567","article-title":"Editorial: new advancement in tumor microenvironment remodeling and cancer therapy","volume":"12","author":"Yao","year":"2024","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.prp.2024.155406_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/365192","article-title":"The possible role of Mena protein and its splicing-derived variants in embryogenesis, carcinogenesis, and tumor invasion: a systematic review of the literature","volume":"2013","author":"Gurzu","year":"2013","journal-title":"Biomed. Res Int"},{"key":"10.1016\/j.prp.2024.155406_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor microenvironment as a therapeutic target in cancer","volume":"221","author":"Xiao","year":"2021","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.prp.2024.155406_bib11","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911131","article-title":"Sarcoma treatment in the era of molecular medicine","volume":"12","author":"Gr\u00fcnewald","year":"2020","journal-title":"EMBO Mol. Med"},{"key":"10.1016\/j.prp.2024.155406_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s43018-024-00743-y","article-title":"Sarcoma microenvironment cell states and ecosystems are associated with prognosis and predict response to immunotherapy","author":"Subramanian","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.prp.2024.155406_bib13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s11547-018-0882-7","article-title":"The pathology of soft tissue sarcomas","volume":"124","author":"Sbaraglia","year":"2019","journal-title":"Radio. Med"},{"key":"10.1016\/j.prp.2024.155406_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.32074\/1591-951X-213","article-title":"The 2020 WHO classification of soft tissue tumours: news and perspectives","volume":"113","author":"Sbaraglia","year":"2020","journal-title":"Pathologica"},{"issue":"2","key":"10.1016\/j.prp.2024.155406_bib15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00428-024-03736-5","article-title":"Current challenges and practical aspects of molecular pathology for bone and soft tissue tumor.","volume":"484","author":"de Alava","year":"2024","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2024.155406_bib16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/PAP.0000000000000284","article-title":"The 2020 WHO classification of tumors of soft tissue: selected changes and new entities","volume":"28","author":"Choi","year":"2021","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4132\/jptm.2022.10.18","article-title":"What\u2019s new in soft tissue and bone pathology 2022\u2013updates from the WHO classification 5th edition","volume":"56","author":"Kao","year":"2022","journal-title":"J. Pathol. Transl. Med"},{"issue":"1","key":"10.1016\/j.prp.2024.155406_bib18","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s41467-024-45306-y","article-title":"Proteomic characterization identifies clinically relevant subgroups of soft tissue sarcoma","volume":"15","author":"Tang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2024.155406_bib19","doi-asserted-by":"crossref","DOI":"10.1007\/s00256-024-04584-9","article-title":"Recent advances in molecular profiling of bone and soft tissue tumors","author":"Baumhoer","year":"2024","journal-title":"Skelet. Radio."},{"key":"10.1016\/j.prp.2024.155406_bib20","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00000478-199409000-00006","article-title":"Spindle cell liposarcoma, a hitherto unrecognized variant of liposarcoma analysis of six cases","volume":"18","author":"Dei Tos","year":"1994","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib21","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/PAS.0000000000000770","article-title":"Atyp-ical spindle cell lipomatous tumor","volume":"41","author":"Mari\u00f1o-Enriquez","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib22","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/PAS.0000000000000936","article-title":"\u201cAtypical\u201d pleomorphic lipoma-tous tumor","volume":"41","author":"Creytens","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib23","first-page":"1531","article-title":"Molecular aberrations of the G1-S checkpoint in myxoid and round cell lipo-sarcoma","volume":"151","author":"Dei Tos","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/his.12311","article-title":"Liposarcomas: diagnostic pitfalls and new insights","volume":"64","author":"Dei Tos","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2024.155406_bib25","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/PAS.0000000000001002","article-title":"Novel EWSR1-SMAD3 gene fusions in a group of acral fibroblastic spindle cell neoplasms","volume":"42","author":"Kao","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib26","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/modpathol.2013.139","article-title":"Superficial CD34-positive fibroblastic tumor: report of 18 cases of a distinctive low-grade mesenchymal neoplasm of intermediate (borderline) malignancy","volume":"27","author":"Carter","year":"2014","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib27","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/PAS.0b013e31823defbe","article-title":"Angiofibroma of Soft Tissue","volume":"36","author":"Mari\u00f1o-Enr\u00edquez","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib28","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/gcc.21939","article-title":"Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon re-ceptor target genes.","volume":"51","author":"Jin","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.prp.2024.155406_bib29","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/PAS.0000000000001927","article-title":"Su-perficial CD34-positive fibroblastic tumor","volume":"46","author":"Anderson","year":"2022","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2022.151937","article-title":"Superficial CD34-positive fibroblastic tumor (SCPFT): a review of pathological and clinical features","volume":"58","author":"Salah","year":"2022","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1017310","article-title":"EWSR1::SMAD3-rearranged fibroblastic tumor: a case with twice recurrence and litera-ture review","volume":"12","author":"Yang","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.prp.2024.155406_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2019.104291","article-title":"EWSR1-SMAD3 positive fibroblastic tumor","volume":"110","author":"Zhao","year":"2019","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/1066896920938124","article-title":"EWSR1-SMAD3 -Positive Fibroblastic Tumor","volume":"29","author":"Foot","year":"2021","journal-title":"Int J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib34","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/modpathol.2017.54","article-title":"Risk assessment in solitary fibrous tumors: validation and refinement of a risk stratification model","volume":"30","author":"Demicco","year":"2017","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib35","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1097\/00000478-200108000-00006","article-title":"Mammary-type myofibroblastoma of soft tissue","volume":"25","author":"McMenamin","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib36","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/PAS.0000000000000540","article-title":"Mammary-type myofibroblastoma","volume":"40","author":"Howitt","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib37","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1097\/PAS.0b013e3181e4f32a","article-title":"Primary vascular tumors and tumor-like lesions of the kidney: a clini-copathologic analysis of 25 cases","volume":"34","author":"Brown","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib38","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00261-016-0690-2","article-title":"Anastomosing hemangio-mas: locations of occurrence, imaging features, and diagnosis with percutaneous biopsy.","volume":"41","author":"O\u2019Neill","year":"2016","journal-title":"Abdom. Radiol."},{"key":"10.1016\/j.prp.2024.155406_bib39","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1097\/PAS.0b013e3181ad30a7","article-title":"Anastomosing hemangioma of the genitourinary tract","volume":"33","author":"Montgomery","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib40","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1097\/PAS.0b013e3181ad30a7","article-title":"Anastomosing hemangioma of the genitourinary tract","volume":"33","author":"Montgomery","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib41","doi-asserted-by":"crossref","first-page":"240","DOI":"10.5858\/arpa.2018-0264-RS","article-title":"Anastomosing Hemangioma: Short Review of a Benign Mimicker of Angiosarcoma","volume":"144","author":"Lappa","year":"2020","journal-title":"Arch. Pathol. Lab Med"},{"key":"10.1016\/j.prp.2024.155406_bib42","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/gcc.22073","article-title":"Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma","volume":"52","author":"Antonescu","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.prp.2024.155406_bib43","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/cpt.1946","article-title":"Developing drugs for tissue-agnostic indications: a paradigm shift in leveraging cancer biology for precision medicine","volume":"109","author":"Seligson","year":"2021","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.prp.2024.155406_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/gcc.22745","article-title":"Most gene fusions in cancer are stochastic events","author":"Johansson","year":"2019","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.prp.2024.155406_bib45","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1593\/neo.12930","article-title":"Re-tained heterodisomy is associated with high gene expression in hyperhaploid inflammatory leiomyosarcoma","volume":"14","author":"Nord","year":"2012","journal-title":"Neoplasia"},{"key":"10.1016\/j.prp.2024.155406_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00368","article-title":"Epstein\u2013Barr Virus+ smooth muscle tumors as manifestation of primary immunodefi-ciency disorders.","volume":"9","author":"Magg","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.prp.2024.155406_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2008\/859407","article-title":"EBV-associated smooth muscle neoplasms: solid tumors arising in the presence of immunosuppression and autoimmune diseases","volume":"2008","author":"Moore Dalal","year":"2008","journal-title":"Sarcoma"},{"key":"10.1016\/j.prp.2024.155406_bib48","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/106689690501300210","article-title":"So-called \u201cinflammatory leiomyosarcoma\u201d: a series of 3 cases providing additional in-sights into a rare entity","volume":"13","author":"Chang","year":"2005","journal-title":"Int J. Surg. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2024.155406_bib49","article-title":"Rhabdomyosarcoma","volume":"5","author":"Skapek","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.prp.2024.155406_bib50","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/PAS.0000000000000612","article-title":"Frequent HRAS mutations in malignant ectomesenchymoma","volume":"40","author":"Huang","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib51","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1200\/JCO.2018.77.9694","article-title":"Addition of vincristine and iri-notecan to vincristine, dactinomycin, and cyclophosphamide does not improve out-come for intermediate-risk rhabdomyosarcoma: a report from the children\u2019s oncology group","volume":"36","author":"Hawkins","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2024.155406_bib52","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1245\/s10434-021-09620-9","article-title":"Why we still need the better risk classification for GIST","volume":"28","author":"Rutkowski","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.prp.2024.155406_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100812","article-title":"Prognostic indicators for gastrointestinal stromal tumors: a review","volume":"13","author":"Zhang","year":"2020","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.prp.2024.155406_bib54","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/PAS.0b013e3182a0a150","article-title":"Malignant Melanotic Schwannian Tumor","volume":"38","author":"Torres-Mora","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib55","unstructured":"F. GaillardMelanotic nerve sheath tumour Radiopaedia.org , Radiopaedia.org , 2017, , 10.53347\/rID-53324."},{"key":"10.1016\/j.prp.2024.155406_bib56","doi-asserted-by":"crossref","first-page":"8735","DOI":"10.12998\/wjcc.v10.i24.8735","article-title":"Malignant melanotic nerve sheath tumors in the spinal canal of psammomatous and non-psammomatous type: two case reports","volume":"10","author":"Yeom","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.prp.2024.155406_bib57","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.3174\/ajnr.A7691","article-title":"Malignant melanotic nerve sheath tumor","volume":"43","author":"Benson","year":"2022","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.prp.2024.155406_bib58","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.humpath.2024.01.007","article-title":"Updates on WHO classification for small round cell tumors: ewing sarcoma vs. everything else","volume":"147","author":"Dehner","year":"2024","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib59","first-page":"362","article-title":"NTRK-rearranged spindle cell neoplasms: a clinicopathological and molecular study of 13 cases with peculiar characteristics at one of the largest institutions in China","volume":"55","author":"Yin","year":"2023","journal-title":"Pathol. -ogy"},{"key":"10.1016\/j.prp.2024.155406_bib60","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cancergen.2021.10.007","article-title":"NTRK-Rearranged soft tissue neoplasms: a review of evolving diagnostic entities and algorithmic detection methods","volume":"260\u2013261","author":"Surrey","year":"2022","journal-title":"Cancer Genet"},{"key":"10.1016\/j.prp.2024.155406_bib61","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/PAS.0000000000000965","article-title":"BCOR-CCNB3 fusion posi-tive sarcomas","volume":"42","author":"Kao","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib62","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/PAS.0000000000000846","article-title":"Sarcomas With CIC-rearrangements are a distinct pathologic entity with aggressive outcome","volume":"41","author":"Antonescu","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib63","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/his.12985","article-title":"CIC-DUX4 fusion-positive round-cell sarcomas of soft tissue and bone: a single-institution morphological and molecular analy-sis of seven cases","volume":"69","author":"Gambarotti","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2024.155406_bib64","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/gcc.20945","article-title":"High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas","volume":"51","author":"Italiano","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.prp.2024.155406_bib65","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/s41379-019-0301-1","article-title":"Clinical, pathological, and genomic features of EWSR1-PATZ1 fusion sarcoma","volume":"32","author":"Bridge","year":"2019","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib66","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/PAS.0000000000001183","article-title":"Spindle and round cell sarcoma With EWSR1-PATZ1 gene fusion","volume":"43","author":"Chougule","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib67","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/PAS.0000000000001260","article-title":"EWSR1-NFATC2 transloca-tion-associated sarcoma clinicopathologic findings in a rare aggressive primary bone or soft tissue tumor","volume":"43","author":"Wang","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib68","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2559.2005.02288.x","article-title":"Grading of soft tissue sarcomas: the challenge of providing precise information in an imprecise world","volume":"48","author":"Deyrup","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2024.155406_bib69","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4103\/nmj.NMJ_226_16","article-title":"Histopathological spectrum of soft-tissue tumors with immunohistochemistry correlation and FNCLCC grading: a North Indian Experience","volume":"58","author":"Singh","year":"2017","journal-title":"Niger. Med J."},{"key":"10.1016\/j.prp.2024.155406_bib70","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2045-3329-1-6","article-title":"Guidelines for histopathological specimen examination and diagnostic reporting of primary bone tumours","volume":"1","author":"Mangham","year":"2011","journal-title":"Clin. Sarcoma Res"},{"key":"10.1016\/j.prp.2024.155406_bib71","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jjco\/hyy157","article-title":"New TNM classification (AJCC eighth edition) of bone and soft tissue sarcomas: JCOG bone and soft tissue tumor study group","volume":"49","author":"Tanaka","year":"2019","journal-title":"Jpn J. Clin. Oncol."},{"key":"10.1016\/j.prp.2024.155406_bib72","first-page":"121","article-title":"Approach to the diagnosis of soft tissue tumors. Enzinger and Weiss\u2019s","author":"Goldblum","year":"2020","journal-title":"Soft Tissue Tumors"},{"key":"10.1016\/j.prp.2024.155406_bib73","series-title":"Practical Soft Tissue Pathology: a Diagnostic Approach","first-page":"513","article-title":"Applications of Molecular Testing to Differential Diagno-sis","author":"Wang","year":"2019"},{"key":"10.1016\/j.prp.2024.155406_bib74","doi-asserted-by":"crossref","first-page":"5934","DOI":"10.3390\/ijms24065934","article-title":"The recent advances in molecular diagnosis of soft tissue tumors","volume":"24","author":"Choi","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2024.155406_bib75","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00428-009-0828-5","article-title":"Molecular pathology of sarcomas: concepts and clinical implications","volume":"456","author":"Bov\u00e9e","year":"2010","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2024.155406_bib76","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/gcc.23025","article-title":"Advances in sarcoma molecu-lar diagnostics","volume":"61","author":"Wang","year":"2022","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.prp.2024.155406_bib77","first-page":"690","article-title":"Diagnostic immunohistochemistry of soft tissue and bone tumors: an update on biomarkers that correlate with molecular alterations","volume":"11","author":"Anderson","year":"2021","journal-title":"Di-agnostics"},{"key":"10.1016\/j.prp.2024.155406_bib78","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.5858\/arpa.2016-0417-RA","article-title":"Soft tissue tumor immuno-histochemistry update: illustrative examples of diagnostic pearls to avoid pitfalls.","volume":"141","author":"Wei","year":"2017","journal-title":"Arch. Pathol. Lab Med"},{"key":"10.1016\/j.prp.2024.155406_bib79","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1038\/modpathol.2013.177","article-title":"Novel uses of immunohistochemistry in the diagnosis and classi-fication of soft tissue tumors","volume":"27","author":"Hornick","year":"2014","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib80","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/his.12138","article-title":"SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours","volume":"63","author":"Conner","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2024.155406_bib81","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00125480-200205000-00003","article-title":"MyoD1 and myogenin expression in human neoplasia: a review and update","volume":"9","author":"Folpe","year":"2002","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib82","first-page":"1799","article-title":"Expression of myo-genic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood","volume":"147","author":"Wang","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib83","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/01.pap.0000194628.58501.71","article-title":"The diagnostic Value of \u03b2-catenin immunohisto-chemistry","volume":"12","author":"Montgomery","year":"2005","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib84","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1097\/01.pas.0000170343.09562.39","article-title":"MDM2 and CDK4 immunostainings are useful adjuncts in di-agnosing well-differentiated and dedifferentiated liposarcoma subtypes","volume":"29","author":"Binh","year":"2005","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib85","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1309\/AJCP45SSNAOPXYXU","article-title":"Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics","volume":"135","author":"Foo","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib86","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/PAS.0b013e318210c268","article-title":"MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma","volume":"35","author":"Doyle","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib87","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/PAI.0b013e3181d27ec8","article-title":"DOG1 for the DIag-nosis of Gastrointestinal Stromal Tumor (GIST): comparison between 2 different anti-bodies","volume":"18","author":"Lopes","year":"2010","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.prp.2024.155406_bib88","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2020.38.15_suppl.e23528","article-title":"The impact of next generation sequencing on sarcoma diagnosis","volume":"38","author":"Zhao","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2024.155406_bib89","doi-asserted-by":"crossref","DOI":"10.1038\/s41416-024-02674-y","article-title":"UK guidelines for the management of soft tissue sarcomas","author":"Hayes","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2024.155406_bib90","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/PAS.0000000000001564","article-title":"DDIT3 immunohistochemistry is a useful tool for the diagnosis of myxoid liposar-coma","volume":"45","author":"Scapa","year":"2021","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib91","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/modpathol.2013.247","article-title":"STAT6 is amplified in a subset of dedif-ferentiated liposarcoma","volume":"27","author":"Doyle","year":"2014","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib92","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00401-013-1117-6","article-title":"Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein","volume":"125","author":"Schweizer","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.prp.2024.155406_bib93","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/PAS.0000000000000137","article-title":"STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors","volume":"38","author":"Yoshida","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib94","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/modpathol.2013.164","article-title":"Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics","volume":"27","author":"Doyle","year":"2014","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib95","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng.2509","article-title":"Iden-tification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing.","volume":"45","author":"Robinson","year":"2013","journal-title":"Nat. Genet"},{"key":"10.1016\/j.prp.2024.155406_bib96","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ng.2522","article-title":"Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors","volume":"45","author":"Chmielecki","year":"2013","journal-title":"Nat. Genet"},{"key":"10.1016\/j.prp.2024.155406_bib97","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/PAS.0b013e318200cfd5","article-title":"Epithelioid inflammatory myofibroblastic sarcoma","volume":"35","author":"Mari\u00f1o-Enr\u00edquez","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib98","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1470-2045(18)30119-0","article-title":"Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1\/2 study","volume":"19","author":"Laetsch","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.prp.2024.155406_bib99","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/PAS.0000000000001062","article-title":"Pan-Trk immunohistochemistry identifies NTRK rear-rangements in pediatric mesenchymal tumors","volume":"42","author":"Rudzinski","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib100","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/gcc.22073","article-title":"Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma","volume":"52","author":"Antonescu","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.prp.2024.155406_bib101","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/PAS.0000000000000795","article-title":"FOSB is a useful diagnostic marker for pseudomyogenic hemangioendothelioma","volume":"41","author":"Hung","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib102","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/gcc.22891","article-title":"A novel CLTC-FOSB gene fu-sion in pseudomyogenic hemangioendothelioma of bone","volume":"60","author":"Bridge","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.prp.2024.155406_bib103","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/PAS.0000000000000469","article-title":"Frequent FOS gene rearrangements in epithe-lioid hemangioma","volume":"39","author":"Huang","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib104","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/PAS.0b013e318191614f","article-title":"PAX immunoreactivity identifies alveo-lar rhabdomyosarcoma","volume":"33","author":"Sullivan","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib105","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1097\/PAS.0b013e3181abe137","article-title":"PAX5 Expression in Rhab-domyosarcoma","volume":"33","author":"Morgenstern","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib106","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41379-020-00719-0","article-title":"Immunohistochemical detection of PAX-FOXO1 fusion proteins in alveolar rhabdomyosarcoma using breakpoint specific monoclonal antibodies","volume":"34","author":"Azorsa","year":"2021","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib107","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semcdb.2015.09.017","article-title":"PAX3 and PAX7 as upstream regulators of myogene-sis.","volume":"44","author":"Buckingham","year":"2015","journal-title":"Semin Cell Dev. Biol."},{"key":"10.1016\/j.prp.2024.155406_bib108","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26645","article-title":"Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: a report from the Children\u2019s Oncology Group","volume":"64","author":"Rudzinski","year":"2017","journal-title":"Pedia Blood Cancer"},{"key":"10.1016\/j.prp.2024.155406_bib109","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/modpathol.2012.153","article-title":"Loss of expression of SDHA predicts SDHA mutations in gastrointestinal stromal tumors","volume":"26","author":"Wagner","year":"2013","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib110","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41379-019-0287-8","article-title":"Histone H3K27 dimethyl loss is highly specific for malignant peripheral nerve sheath tumor and distinguishes true PRC2 loss from isolated H3K27 trimethyl loss","volume":"32","author":"Marchione","year":"2019","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib111","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/his.14223","article-title":"Radiation-associated sarcomas other than malignant peripheral nerve sheath tumours demonstrate loss of histone H3K27 trimethylation","volume":"78","author":"Panse","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2024.155406_bib112","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/modpathol.2016.45","article-title":"Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival","volume":"29","author":"Cleven","year":"2016","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib113","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/ng.3095","article-title":"PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors","volume":"46","author":"Lee","year":"2014","journal-title":"Nat. Genet"},{"key":"10.1016\/j.prp.2024.155406_bib114","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/sj.onc.1204074","article-title":"The der(17)t(X;17)(p11;q25) of human alve-olar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.","volume":"20","author":"Ladanyi","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2024.155406_bib115","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/his.14190","article-title":"When used together SS18\u2013SSX fusion-specific and SSX C-terminus immunohistochemistry are highly specific and sensitive for the diagnosis of synovial sarcoma and can replace FISH or molecular testing in most cases","volume":"77","author":"Zaborowski","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2024.155406_bib116","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/PAS.0000000000001628","article-title":"The SS18-SSX anti-body has perfect specificity for the SS18-SSX fusion protein","volume":"45","author":"Perret","year":"2021","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib117","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/PAS.0b013e3181f17ac0","article-title":"A distinctive subset of PEComas harbors TFE3 gene fusions","volume":"34","author":"Argani","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib118","first-page":"690","article-title":"Diagnostic immunohistochemistry of soft tissue and bone tumors: an update on biomarkers that correlate with molecular alterations","volume":"11","author":"Anderson","year":"2021","journal-title":"Di-agnostics"},{"key":"10.1016\/j.prp.2024.155406_bib119","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/00000478-200006000-00008","article-title":"Immunohistochemical expression of WT1 by desmoplastic small round cell tumor","volume":"24","author":"Barnoud","year":"2000","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib120","first-page":"1584","article-title":"Detection of chimeric transcripts in desmoplastic small round cell tumor and related developmental tumors by reverse tran-scriptase polymerase chain reaction. A specific diagnostic assay","volume":"147","author":"de Alava","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib121","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/his.14231","article-title":"NKX3.1 immunoreactivity is not identified in mesenchymal chondrosarcoma: a 25-case cohort study","volume":"78","author":"Chen","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2024.155406_bib122","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1038\/s41379-020-0542-z","article-title":"NFATc2-rearranged sarcomas: clinico-pathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker","volume":"33","author":"Perret","year":"2020","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib123","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/modpathol.2016.31","article-title":"Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma","volume":"29","author":"Hung","year":"2016","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib124","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/PAS.0000000000000772","article-title":"DUX4 immunohistochemistry is a highly sensitive and specific marker for CIC-DUX4 Fu-sion-positive round cell tumor","volume":"41","author":"Siegele","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib125","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/modpathol.2016.140","article-title":"Evaluation of ETV4 and WT1 expression in CIC-rearranged sarcomas and histologic mimics","volume":"29","author":"Hung","year":"2016","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib126","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/gcc.20945","article-title":"High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas","volume":"51","author":"Italiano","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.prp.2024.155406_bib127","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/PAS.0000000000000846","article-title":"Sarcomas With CIC-rearrangements are a distinct pathologic entity with aggressive outcome","volume":"41","author":"Antonescu","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib128","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1097\/PAS.0000000000000697","article-title":"BCOR overexpression is a highly sensitive marker in round cell sarcomas with BCOR genetic abnormalities","volume":"40","author":"Kao","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib129","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1097\/PAS.0000000000000934","article-title":"Clinicopathologic diversity of undif-ferentiated sarcoma with BCOR-CCNB3 fusion","volume":"41","author":"Matsuyama","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib130","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/PAS.0000000000000965","article-title":"BCOR-CCNB3 fusion posi-tive sarcomas","volume":"42","author":"Kao","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2024.155406_bib131","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/ng.1107","article-title":"A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion","volume":"44","author":"Pierron","year":"2012","journal-title":"Nat. Genet"},{"key":"10.1016\/j.prp.2024.155406_bib132","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/his.12945","article-title":"The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastoma","volume":"69","author":"Amary","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2024.155406_bib133","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/ng.2814","article-title":"Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone","volume":"45","author":"Behjati","year":"2013","journal-title":"Nat. Genet"},{"key":"10.1016\/j.prp.2024.155406_bib134","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/cjp2.13","article-title":"Diagnostic value of H3F3A mutations in giant cell tumour of bone com-pared to osteoclast-rich mimics.","volume":"1","author":"Presneau","year":"2015","journal-title":"J. Pathol. Clin. Res"},{"key":"10.1016\/j.prp.2024.155406_bib135","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.3390\/cancers14102548","article-title":"The molecular biology of soft tissue sarcomas: current knowledge and future perspectives","volume":"14","author":"Vibert","year":"2022","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.prp.2024.155406_bib136","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jmoldx.2018.11.002","article-title":"Molecular pathology of bone tumors","volume":"21","author":"Lam","year":"2019","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.prp.2024.155406_bib137","article-title":"A comprehensive understanding of the genomic bone tumor land-scape: a multicenter prospective study","volume":"12","author":"Xie","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.prp.2024.155406_bib138","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1158\/0008-5472.CAN-20-0512","article-title":"A global and integrated analysis of CIN-SARC-associated genetic defects","volume":"80","author":"Lesluyes","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.prp.2024.155406_bib139","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/cam4.5015","article-title":"CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: results from the ISG-STS 1001 study","volume":"12","author":"Frezza","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.prp.2024.155406_bib140","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1186\/s12885-021-08878-2","article-title":"Molecular profiling of ad-vanced soft-tissue sarcomas: the MULTISARC randomized trial.","volume":"21","author":"Italiano","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2024.155406_bib141","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16051042","article-title":"Soft tissue sarcomas: treatment and management","volume":"16","author":"Miwa","year":"2024","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.prp.2024.155406_bib142","doi-asserted-by":"crossref","DOI":"10.1200\/EDBK_432234","article-title":"Immunotherapy in sarcoma: current data and promising strategies","volume":"44","author":"Wood","year":"2024","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824003170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824003170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T19:21:36Z","timestamp":1735154496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033824003170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":142,"alternative-id":["S0344033824003170"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2024.155406","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenetic and molecular classifications of soft tissue and bone tumors: A 2024 update","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2024.155406","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"155406"}}